Short description
MetaFines is researching and developing anti-cancer drugs using cancer metabolism.
Description
MetaFines is a biopharma firm that creates anticancer medications with the goal of preventing the spread of cancer. By extending and reconfiguring the indications of off-label medications for terminal tumors, the company creates minimal anticancer pharmaceuticals. It also provides subcutaneous injections and therapies, allowing patients to fight cancer and enhance their standard of living with cancer metabolism.
The company develops ow-toxic medicines for metabolic cancer. This low-toxic metabolic anti-cancer agent is distinguished by being created so that metabolic anti-cancer agents that limit cell growth but operate via various pathways can work in concert with one another.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Seongnam, Kyonggi-do, South Korea, Asia
Founded on
October 8, 2018
Non-profit?
No
Acquired?
No
Investors
Noway Youcantaccess, Uh Ohhhh, Uh Ohhhh, Noway Youcantaccess, Uh Ohhhh, Noaccess, Noaccess, Blurry Noaccess, Noaccess
Sign in for full access